Evidence map›Paper›PMID 27144576›Full record

ArticleViruses2016

Conserved Endonuclease Function of Hantavirus L Polymerase.

Sylvia Rothenberger, Giulia Torriani, Maria U Johansson, Stefan Kunz, Olivier Engler

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Pharmacophores of Influenza Virus PA Endonuclease Inhibitors.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sylvia RothenbergerInstitute of Microbiology, University Hospital Center and University of Lausanne, Lausanne CH-1011, Switzerland. Sylvia.Rothenberger-Aubert@chuv.ch.
Giulia TorrianiInstitute of Microbiology, University Hospital Center and University of Lausanne, Lausanne CH-1011, Switzerland. Giulia.Torriani@chuv.ch.
Maria U JohanssonSIB Swiss Institute of Bioinformatics, Lausanne CH-1015, Switzerland. maria.johansson@isb-sib.ch.
Stefan KunzInstitute of Microbiology, University Hospital Center and University of Lausanne, Lausanne CH-1011, Switzerland. Stefan.Kunz@chuv.ch.
Olivier EnglerSPIEZ Laboratory, Austrasse, Spiez CH-3700, Switzerland. oliver.engler@babs.admin.ch.
University of Lausanne · CHSIB Swiss Institute of Bioinformatics · CHSpiez Laboratory · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hantaviruses are important emerging pathogens belonging to the Bunyaviridae family. Like other segmented negative strand RNA viruses, the RNA-dependent RNA polymerase (RdRp) also known as L protein of hantaviruses lacks an intrinsic "capping activity". Hantaviruses therefore employ a "cap snatching" strategy acquiring short 5' RNA sequences bearing 5'cap structures by endonucleolytic cleavage from host cell transcripts. The viral endonuclease activity implicated in cap snatching of hantaviruses has been mapped to the N-terminal domain of the L protein. Using a combination of molecular modeling and structure-function analysis we confirm and extend these findings providing evidence for high conservation of the L endonuclease between Old and New World hantaviruses. Recombinant hantavirus L endonuclease showed catalytic activity and a defined cation preference shared by other viral endonucleases. Based on the previously reported remarkably high activity of hantavirus L endonuclease, we established a cell-based assay for the hantavirus endonuclase function. The robustness of the assay and its high-throughput compatible format makes it suitable for small molecule drug screens to identify novel inhibitors of hantavirus endonuclease. Based on the high degree of similarity to RdRp endonucleases, some candidate inhibitors may be broadly active against hantaviruses and other emerging human pathogenic Bunyaviruses.

Indexed as

AnimalsCell LineCricetinaeDNA Mutational AnalysisEndonucleasesModels, MolecularOrthohantavirusProtein DomainsRecombinant ProteinsRNA-Dependent RNA PolymeraseSubstrate SpecificityViral ProteinsEndonucleasesL protein, hantavirusRecombinant ProteinsRNA-Dependent RNA PolymeraseViral ProteinsBunyaviridaeemerging diseasesendonucleasehantavirus

Identifiers

PMID27144576
PMCPMC4885073
OpenAlexW2342690750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.